mHealthWatch has learned that GlobalMed has just acquired ORCAS, a premier research and development company in the health technology space.
As a result of the acquisition, the Eugene, Oregon-based company will become a wholly owned subsidiary of GlobalMed.
ORCAS has a long history of blending expertise in behavior change science and the mobile user experience to create innovative software applications that empower patients to become active managers of their own health. From 1989 to 2016, ORCAS received over $65 million in grants from the National Institutes of Health’s Small Business Innovation Research arm, which funded over 120 randomized controlled trials.
This commitment to scientifically validating products prior to their release in the market has been a significant differentiator for ORCAS.
“We believe the future of telehealth will go beyond acute care to deliver prevention and management of chronic conditions,” said GlobalMed CEO and Founder Joel E. Barthelemy. “Whether it’s remote consultations from home or helping patients self-manage between doctor visits, the addition of ORCAS’s expertise in lifestyle behavior change and scientifically validated technology is a natural fit with our telemedicine offerings and will help us transform our best new ideas into products.”